Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 1976GutOpen Access

Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSolko W. SchalmErasmus MCWSW.H.J. SummerskillMayo Clinic in ArizonaGGGary GitnickUniversity of Pisa

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schalm et al. (1976) studied this question.

synapsesocial.com/papers/6a77750dd3a6aa87c6bdc50dhttps://doi.org/10.1136/gut.17.10.781
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis1971 · 566 citations
  2. 2Nonparametric Estimation from Incomplete Observations1958 · 39,549 citations
  3. 3A Serum Antigen (Australia Antigen) in Down's Syndrome, Leukemia, and Hepatitis1967 · 654 citations